ETF Research Center

The ROBO Global Healthcare Technology and Innovation ETF tracks a market-cap selected and weighted index of global healthcare technology companies.

FUND BASICS
Category	Global Equities
Fund Sponsor	Exchange Traded Concepts
Website	roboglobaletfs.com
Inception date	Jun 25, 2019
Assets (mns)	$4
Currency	USD
Expense ratio	68 bp
Distributions	Annually

FUND STRUCTURE
Regulation	Open-Ended Fund
Custodian
Weighting	Market Cap
Index replication
Uses derivatives	No
Options available	No

SECTOR BREAKDOWN

CONSTITUENT BREAKDOWN
No. of constituents	85
Wgt avg mkt cap (mns)	$21,197
Large cap (>$10bn)	36.9%
Mid cap ($2-10bn)	38.1%
Small cap (<$2bn)	23.3%
Developed mkts	100.0%
Emerging mkts	0.0%

TOP TEN HOLDINGS
Total	17.2 %
ARROWHEAD PHARMACEUTICALS, INC.	1.9 %
TELADOC INC	1.8 %
DEXCOM INC	1.7 %
NATERA INC	1.7 %
ALIGN TECHNOLOGY INC	1.7 %
PENUMBRA, INC.	1.7 %
QIAGEN NV	1.7 %
ABIOMED INC	1.6 %
PING AN HEALTHCARE AND TECHNOLOGY	1.6 %
SIEMENS HEALTHINEERS AG	1.6 %

TOP COUNTRY EXPOSURE
	UNITED STATES	80.1 %
	SWITZERLAND	3.5 %
	NETHERLANDS	2.8 %
	BRITAIN	2.3 %
	CHINA	1.6 %
	GERMANY	1.6 %
	JAPAN	1.4 %
	ITALY	1.4 %
	AUSTRALIA	1.2 %
	SPAIN	1.0 %

HISTORICAL PERFORMANCE info

	Custom date range	Compare to
	thru

Standardized Annual Returns (thru January 01)
Year-to-date	1 year	5 years	10 years	Since Incep.
--	--	--	--	0.0%

Market Correlations
versus...	Beta	R-squared
S&P500	--	--
MSCI EAFE	--	--
MSCI Emg. Mkts.	--	--

Technical Indicators
Recent close	$25.20
30d moving avg.	$23.95
Annualized volatility	0.0%
Short interest (ETF)	0.3%
Relative strength (RSI)	67

Liquidity measures
Avg. volume (thou.)	2
Turnover	1.3%
Bid/Ask (% of price)	0.17%
ADV underlying (mns)	$8,629

Distributions

FINDING ALTERNATIVE FUNDS

Below is a list of 20 potential alternatives to the Robo Global Healthcare Technology and Innovation ETF based on the alternatives' overlap in portfolio holdings with HTEC. Consider funds with lower expense ratios and/or higher ALTAR Score™ ratings as possible alternatives.

Benchmark ticker:

HTEC

Expense:

68 bp

ALTAR Score™:

0.0%

ALTERNATIVE ETFs BASED ON OVERLAP WITH HTEC
Ticker	Fund Name	Overlap¹ vs HTEC (%)	Expense ratio (bp)	Savings vs HTEC (bp)	ALTAR Score™ (%)	ALTAR vs HTEC (%)
XHE	SPDR S&P Health Care Equipment	35.2	35	33	2.2	+2.2
RYH	Invesco S&P Equal Weight Healthcare	26.4	40	28	7.2	+7.2
JHMH	John Hancock Multifactor Health Care	23.2	40	28	6.8	+6.8
FXH	First Trust Health Care Alphadex	22.9	63	5	7.2	+7.2
GDNA	Goldman Sachs Motif Human Evolution	22.8	50	18	1.0	+1.0
IHI	iShares DJ US Medical Devices	21.9	43	25	3.8	+3.8
FHLC	Fidelity MSCI Health Care	21.5	8	60	6.0	+6.0
VHT	Vanguard Health Care	21.2	10	58	5.9	+5.9
IYH	iShares US Healthcare	20.4	43	25	6.4	+6.4
IXJ	iShares S&P Global Healthcare	20.2	46	22	6.5	+6.5
PTH	Invesco DWA Healthcare Momentum	20.1	60	8	-1.4	-1.4
LNGR	Global X Longevity Thematic	19.8	50	18	3.7	+3.7
IEHS	iShares Evolved U.S. Healthcare Staples	19.8	18	50	6.0	+6.0
XLV	Health Care Select Sector SPDR	18.3	13	55	7.3	+7.3
ROBO	Robo Global Robotics & Automation	14.7	95	-27	3.7	+3.7
GNOM	Global X Genomics & Biotechnology	14.3	68	0	-6.4	-6.4
ARKG	ARK Genomic Revolution Multi-Sector	13.8	75	-7	-4.2	-4.2
BTEC	Principal Healthcare Innovators Index	13.2	42	26	-4.5	-4.5
PSCH	Invesco S&P Small Cap Health Care	13.1	29	39	2.9	+2.9
XBI	SPDR S&P Biotech ETF	12.7	35	33	-5.0	-5.0

¹Overlap is the percentage of holdings by weight that are identical. For example, if Fund A has a 2% position in Apple, Inc. (AAPL) and Fund B has a 5% position, their overlapping position in AAPL is 2%.

Content on this tab for subscribers only**

RESULTS & ESTIMATES

	2014	2015	2016	2017	2018	2019E	2020E
Sales per share	**	**	**	**	**	**	**
Earnings per share	**	**	**	**	**	**	**
Dividends per share	**	**	**	**	**	**	**
Book value per share	**	**	**	**	**	**	**

Sales per share growth		**%	**%	**%	**%	**%	**%
EPS growth		**%	**%	**%	**%	**%	**%

Sales per share growth		**%	**%	**%	**%	**%	**%
EPS growth		**%	**%	**%	**%	**%	**%

OTHER FUNDAMENTAL METRICS

Long term EPS growth est.	**%		Debt-to-equity	**x
Asset turnover	**%		Assets-to-equity	**x

Return on equity

Revision activity*

*Six months ago = 100

Net margins

Compound annual growth rates

Content on this tab for subscribers only

VALUATION METRICS

	2018	2019E	2020E
Price-to-sales	**	**	**
Price-to-earnings	**	**	**
Price-to-cash flow	**	**	**
Price-to-growth	**	**	**
Price-to-book value	**	**	**
Yield	**	**	**

Historical valuation trends

Forward multiple:	Robo Global Healthcare Technology and Innovation
Relative to:	S&P500	MSCI EAFE	MSCI Emg. Mkts.	Other ETF:

AVOID

Not worthwhile for most investors. A rating of AVOID is assigned to ETFs with ALTAR Scores in the lowest quintile (the bottom 20%) of their category. Often, funds in this category consist of stocks with little if any history or expectation of profitability, and as a result our fundamentally-driven analysis may not be relevant.

ALTAR Score™

Calculation of ALTAR Score™
Avg. Return on Equity	3.3	%
Divided by: Fwd. P/BV	4.8	x
Less: Expense ratio	68	bp
Equals: ALTAR Score	0.0	%

More information on ALTAR Score™

MODERN PORTFOLIO THEORY info

CONSENSUS RECOMMENDATIONS: FUND CONSTITUENTS

COMPOSITE RATING	1.41	CATEGORY AVERAGE	1.54

The composite rating is a weighted average of analysts' consensus recommendations for individual ETF constituents, based on the following scale: BUY = 1; OVERWEIGHT = 1.5, HOLD = 2; UNDERWEIGHT = 2.5; and SELL = 3. Readers are cautioned that because analyst ratings tend to be inflated, the composite score may be more useful as a relative measure of sentiment between funds rather than as a stand-alone recommendation.